MedTrace Logo

Plan A Occlusion and Reversal System Feasibility Study

NCT07361120 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-01-22

No results posted yet for this study

Summary

Prospective, multicenter, single-arm, open label, interventional clinical trial investigating the safety and effectiveness of the Plan A Male Contraceptive System to occlude the vas deferens to block the passage of sperm and then be reversed to subsequently allow the passage of sperm through the vas deferens.

Conditions

  • Fertility
  • Fertility, Male
  • Healthy Male Adults

Interventions

DEVICE

Occlusion System

The occlusion system comprised of the Delivery Lumen Access Device and Vasalgel.

Sponsors & Collaborators

  • Clinico Pty Ltd

    collaborator OTHER

  • Next Life Sciences

    lead INDUSTRY

Principal Investigators

  • Homi Zargar, MD · Western Urology

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-31
Primary Completion
2026-08-31
Completion
2026-09-30

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07361120 on ClinicalTrials.gov